Is Edwards Lifesciences (EW) Stock a Sell after Jeanluc Lemercier’s Insider Trading?; Hahn Capital Management Has Cut Its Host Hotels & Resorts (HST) Holding

Edwards Lifesciences Corporation (NYSE:EW) Logo

Hahn Capital Management Llc decreased Host Hotels & Resorts Inc. (HST) stake by 1.55% reported in 2017Q4 SEC filing. Hahn Capital Management Llc sold 18,078 shares as Host Hotels & Resorts Inc. (HST)’s stock declined 8.76%. The Hahn Capital Management Llc holds 1.15 million shares with $22.74 billion value, down from 1.16 million last quarter. Host Hotels & Resorts Inc. now has $14.42 billion valuation. The stock increased 4.06% or $0.75 during the last trading session, reaching $19.23. About 12.64M shares traded or 78.43% up from the average. Host Hotels & Resorts, Inc. (NYSE:HST) has risen 1.97% since April 13, 2017 and is uptrending. It has underperformed by 9.58% the S&P500.

An insider Jeanluc Lemercier who is CVP – EMEA – Canada – Latin Amer of Edwards Lifesciences Corp sold 5,633 shares of the Pinksheet-listed company having a market value near $785,353 U.S Dollars calculated based on $139.4 for each one share. A filing documented published April 11, 2018 with the Security Exchange Commission, made public here, shows more details about the deal. Currently, Mr. Jeanluc, has ownership of 38,840 shares, which accounts for 0.02% of Edwards Lifesciences Corp’s market cap.

The stock increased 1.32% or $1.81 during the last trading session, reaching $139.28. About 1.20M shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 44.06% since April 13, 2017 and is uptrending. It has outperformed by 32.51% the S&P500.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company has market cap of $29.32 billion. It offers transcatheter heart valve therapy products comprising transcatheter aortic heart valves and their delivery systems for the nonsurgical replacement of heart valves. It has a 51.59 P/E ratio. The firm also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral replacement, and minimally invasive aortic heart valve system; and tissue heart valves and repair products, which are used to replace or repair a patientÂ’s diseased or defective heart valve.

Analysts await Edwards Lifesciences Corporation (NYSE:EW) to report earnings on April, 24. They expect $1.10 earnings per share, up 17.02% or $0.16 from last year’s $0.94 per share. EW’s profit will be $231.57 million for 31.65 P/E if the $1.10 EPS becomes a reality. After $0.94 actual earnings per share reported by Edwards Lifesciences Corporation for the previous quarter, Wall Street now forecasts 17.02% EPS growth.

Among 28 analysts covering Edwards Lifesciences Corp (NYSE:EW), 22 have Buy rating, 1 Sell and 5 Hold. Therefore 79% are positive. Edwards Lifesciences Corp has $195 highest and $86 lowest target. $133.78’s average target is -3.95% below currents $139.28 stock price. Edwards Lifesciences Corp had 108 analyst reports since July 30, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Cowen & Co on Friday, October 9. The firm has “Buy” rating by RBC Capital Markets given on Friday, September 1. The rating was maintained by Canaccord Genuity with “Buy” on Thursday, February 15. The company was maintained on Tuesday, May 30 by RBC Capital Markets. The stock has “Mkt Perform” rating by JMP Securities on Wednesday, January 6. On Thursday, February 1 the stock rating was maintained by Jefferies with “Buy”. The stock of Edwards Lifesciences Corporation (NYSE:EW) earned “Sell” rating by Citigroup on Thursday, November 12. Barclays Capital maintained it with “Equalweight” rating and $115 target in Wednesday, July 27 report. The rating was maintained by Barclays Capital with “Overweight” on Friday, February 2. The company was maintained on Friday, May 26 by Jefferies.

Since December 18, 2017, it had 0 insider buys, and 1 insider sale for $1.23 million activity. On Monday, December 18 the insider ABDOO ELIZABETH A sold $1.23 million.

Analysts await Host Hotels & Resorts, Inc. (NYSE:HST) to report earnings on April, 27. They expect $0.40 earnings per share, down 9.09% or $0.04 from last year’s $0.44 per share. HST’s profit will be $299.95 million for 12.02 P/E if the $0.40 EPS becomes a reality. After $0.42 actual earnings per share reported by Host Hotels & Resorts, Inc. for the previous quarter, Wall Street now forecasts -4.76% negative EPS growth.

Among 23 analysts covering Host Hotels & Resorts (NYSE:HST), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Host Hotels & Resorts had 73 analyst reports since July 31, 2015 according to SRatingsIntel. BTIG Research initiated the shares of HST in report on Thursday, August 25 with “Neutral” rating. The stock of Host Hotels & Resorts, Inc. (NYSE:HST) has “Buy” rating given on Wednesday, July 26 by Cantor Fitzgerald. The firm earned “Neutral” rating on Monday, September 26 by Goldman Sachs. The firm has “Buy” rating by Robert W. Baird given on Friday, January 12. The firm has “Buy” rating given on Monday, November 6 by Wells Fargo. As per Thursday, January 7, the company rating was upgraded by Robert W. Baird. The company was downgraded on Monday, January 11 by JMP Securities. Robert W. Baird maintained Host Hotels & Resorts, Inc. (NYSE:HST) on Friday, November 10 with “Buy” rating. The firm earned “Hold” rating on Wednesday, June 7 by RBC Capital Markets. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, September 6.

Host Hotels & Resorts, Inc. (NYSE:HST) Institutional Positions Chart

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: